Home » Bristol-Myers Squibb Revenue Falls As Expected
Bristol-Myers Squibb Revenue Falls As Expected
Bristol-Myers Squibb sales fell 9 percent after the loss of patents on Avapro and Plavix.
The Pharma Letter
The Pharma Letter
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May